Surgical outcomes in children with drug-resistant epilepsy and hippocampal sclerosis

被引:2
|
作者
Alashjaie, Ream [1 ]
Kerr, Elizabeth N. [2 ]
AlShoumer, Azhar [3 ]
Hawkins, Cynthia [3 ]
Yau, Ivanna [1 ]
Weiss, Shelly [1 ]
Ochi, Ayako [1 ]
Otsubo, Hiroshi [1 ]
Krishnan, Pradeep [4 ]
Widjaja, Elysa [5 ]
Ibrahim, George M. [6 ]
Donner, Elizabeth J. [1 ]
Jain, Puneet [1 ]
机构
[1] Univ Toronto, Hosp Sick Children, Dept Pediat, Epilepsy Program,Div Neurol, Toronto, ON, Canada
[2] Univ Toronto, Hosp Sick Children, Dept Psychol, Toronto, ON, Canada
[3] Hosp Sick Children, Dept Lab Med & Pathol, Div Neuropathol, Toronto, ON, Canada
[4] Univ Toronto, Hosp Sick Children, Dept Diagnost Imaging, Toronto, ON, Canada
[5] Lurie Childrens Hosp Chicago, Dept Med Imaging, Chicago, IL USA
[6] Univ Toronto, Hosp Sick Children, Div Neurosurg, Toronto, ON, Canada
关键词
Epilepsy surgery; Anterior temporal lobectomy; Amygdalo-hippocampectomy; Mesial temporal lobe sclerosis; Focal cortical dysplasia; Pediatric; Outcomes; TEMPORAL-LOBE EPILEPSY; FEBRILE STATUS EPILEPTICUS; CONSENSUS CLASSIFICATION; TASK-FORCE; SURGERY; DYSPLASIA; LOBECTOMY; ADULTS;
D O I
10.1016/j.eplepsyres.2024.107367
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: Hippocampal sclerosis (HS) is a common surgical substrate in adult epilepsy surgery cohorts but variably reported in various pediatric cohorts. Objective: We aimed to study the epilepsy phenotype, radiological and pathological variability, seizure and neurocognitive outcomes in children with drug-resistant epilepsy and hippocampal sclerosis (HS) with or without additional subtle signal changes in anterior temporal lobe who underwent surgery. Methods: This retrospective study enrolled children with drug-resistant focal epilepsy and hippocampal sclerosis with or without additional subtle T2-Fluid Attenuated Inversion Recovery (FLAR)/Proton Density (PD) signal changes in anterior temporal lobe who underwent anterior temporal lobectomy with amygdalohippocampectomy. Their clinical, EEG, neuropsychological, radiological and pathological data were reviewed and summarized. Results: Thirty-six eligible patients were identified. The mean age at seizure onset was 3.7 years; 25% had daily seizures at time of surgery. Isolated HS was noted in 22 (61.1%) cases and additional subtle signal changes in ipsilateral temporal lobe in 14 (38.9%) cases. Compared to the normative population, the group mean performance in intellectual functioning and most auditory and visual memory tasks were significantly lower than the normative sample. The mean age at surgery was 12.3 years; 22 patients (61.1%) had left hemispheric surgeries. ILAE class 1 outcomes was seen in 28 (77.8%) patients after a mean follow up duration of 2.3 years. Hippocampal sclerosis was noted pathologically in 32 (88.9%) cases; type 2 (54.5%) was predominant subtype where further classification was possible. Additional pathological abnormalities were seen in 11 cases (30.6%); these had had similar rates of seizure freedom as compared to children with isolated hippocampal sclerosis/gliosis (63.6% vs 84%, p=0.21). Significant reliable changes were observed across auditory and visual memory tasks at an individual level post surgery. Conclusions: Favourable seizure outcomes were seen in most children with isolated radiological hippocampal sclerosis. Patients with additional pathological abnormalities had similar rates of seizure freedom as compared to children with isolated hippocampal sclerosis/gliosis.
引用
收藏
页数:7
相关论文
共 50 条
  • [41] Hippocampal sclerosis is associated with celiac disease type immunity in patients with drug-resistant temporal lobe epilepsy
    Maria Peltola
    Katri Kaukinen
    Pabitra Basnyat
    Jani Raitanen
    Katri Haimila
    Suvi Liimatainen
    Sirpa Rainesalo
    Jukka Peltola
    Journal of Neurology, 2024, 271 : 2596 - 2604
  • [42] Hippocampal sclerosis is associated with celiac disease type immunity in patients with drug-resistant temporal lobe epilepsy
    Peltola, Maria
    Kaukinen, Katri
    Basnyat, Pabitra
    Raitanen, Jani
    Haimila, Katri
    Liimatainen, Suvi
    Rainesalo, Sirpa
    Peltola, Jukka
    JOURNAL OF NEUROLOGY, 2024, 271 (05) : 2596 - 2604
  • [43] Drug-Resistant Epilepsy
    Ricart, Javier J.
    NEW ENGLAND JOURNAL OF MEDICINE, 2011, 365 (23): : 2239 - 2239
  • [44] DRUG-RESISTANT EPILEPSY
    Djibo, Hassane T.
    Digue, B.
    Syla, K.
    Diallo, A.
    Diallo, T.
    Niare, M.
    Diawara, C.
    Guilavogui, F.
    Cisse, A.
    EPILEPSIA, 2013, 54 : 63 - 63
  • [45] Utility of genetic testing in the pre-surgical evaluation of children with drug-resistant epilepsy
    Alsubhi, Sarah
    Berrahmoune, Saoussen
    Dudley, Roy W. R.
    Dufresne, David
    Tremblay, Elisabeth Simard
    Srour, Myriam
    Myers, Kenneth A.
    JOURNAL OF NEUROLOGY, 2024, 271 (05) : 2503 - 2508
  • [46] Utility of genetic testing in the pre-surgical evaluation of children with drug-resistant epilepsy
    Sarah Alsubhi
    Saoussen Berrahmoune
    Roy W. R. Dudley
    David Dufresne
    Elisabeth Simard Tremblay
    Myriam Srour
    Kenneth A. Myers
    Journal of Neurology, 2024, 271 : 2503 - 2508
  • [47] Stiripentol for Drug-Resistant Epilepsy Treatment in Tuberous Sclerosis Complex
    Aungaroon, Gewalin
    Mehta, Amar
    Horn, Paul S.
    Franz, David N.
    PEDIATRIC NEUROLOGY, 2023, 139 : 86 - 92
  • [48] Stiripentol for drug-resistant epilepsy treatment in tuberous sclerosis complex
    Aungaroon, G.
    Franz, D.
    Mehta, A.
    ANNALS OF NEUROLOGY, 2022, 92 : S100 - S100
  • [49] Epilepsy surgery for drug-resistant epileptic spasms in children
    Al Shehhi, W.
    Jain, P.
    Otsubo, H.
    Donner, E.
    Weiss, S.
    Yau, I.
    Ibrahim, G.
    Ochi, A.
    EPILEPSIA, 2023, 64 : 109 - 110
  • [50] Topiramate in drug-resistant epilepsy in children: Retrospective data
    Vittorini, R
    Pieri, I
    Canavese, C
    Capizzi, G
    EPILEPSIA, 2005, 46 : 238 - 238